Diabetes Publish Ahead of Print published online ahead of print June 11, 2007 DOI: 10.2337/db07-0480
Hepatic Lipin 1ß Expression is Diminished in Insulin-Resistant Obese Subjects and is Reactivated by Marked Weight Loss
Michelle A. Croce, B.S.1,
J. Christopher Eagon, M.D.1,
Lori L. LaRiviere, M.A.1,
Kevin M. Korenblat, M.D.1,
Samuel Klein, M.D.1, and
Brian N. Finck, Ph.D.1
1Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO
Correspondence:
bfinck{at}im.wustl.edu
Objective:Lipin 1 plays critical roles in controlling energy metabolism. We sought to determine the expression of lipin 1 isoforms (lipin 1 and ß) in liver and adipose tissue of obese subjects and to evaluate cellular mechanisms involved in the regulation of lipin 1 expression by physiologic stimuli.
Research Design and Methods:The expression of lipin 1 and ß was quantified in liver and adipose tissue of extremely obese (average BMI = 60.8 kg/m2) human subjects undergoing gastric bypass surgery (GBS). Secondly, the expression of lipin 1 was evaluated in HepG2 cells in response to overexpression of peroxisome proliferator-activated receptor coactivator 1 (PGC-1 ) under normal or hyperinsulinemic conditions.
Results:The expression of lipin 1ß in liver and adipose tissue was inversely related to BMI, fasting plasma insulin concentration, and the HOMA-IR, but was significantly increased by marked weight loss and insulin sensitization following GBS. Hepatic lipin 1ß mRNA levels were strongly correlated with the expression of PGC-1 and overexpression of PGC-1 in HepG2 cells increased lipin 1 expression. Conversely, hyperinsulinemic culture conditions down-regulated the expression of lipin 1ß, PGC-1 , and their known target genes involved in mitochondrial metabolism in HepG2 cells. Finally, overexpression of lipin 1ß or PGC-1 reversed the effect of hyperinsulinemia on the expression of their target genes.
Conclusions:These studies suggest that hepatic lipin 1ß and PGC-1 expression is down-regulated by obesity and obesity-related metabolic perturbations in human subjects, likely due to alterations in insulin concentration or sensitivity.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. A. Fawcett, N. Grimsey, R. J.F. Loos, E. Wheeler, A. Daly, M. Soos, R. Semple, H. Syddall, C. Cooper, S. Siniossoglou, et al.
Evaluating the Role of LPIN1 Variation in Insulin Resistance, Body Weight, and Human Lipodystrophy in U.K. Populations
Diabetes,
September 1, 2008;
57(9):
2527 - 2533.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Diabetes Association.
|
|
| |
|